RICHMOND, Va., Dec. 12, 2018 /PRNewswire/ -- Kaléo, a privately-held pharmaceutical company, today announced that it will offer an authorized generic of its EVZIO® (naloxone HCl injection) take home ...

First and only FDA approved naloxone product specifically indicated for emergency therapy in settings where opioids may be present. EVZIO is now available in the United States by prescription. EVZIO ...

The Food and Drug Administration has approved an auto-injector developed by a Richmond pharmaceutical company for emergency treatment of an overdose involving powerful painkillers. EVZIO is a ...

Kaléo, a privately-held pharmaceutical company, has launched Evzio (naloxone HCl injection) in US markets for the emergency treatment of known or suspected opioid overdose, as manifested by ...

April 5 (Reuters) - Kaleo Inc, which came under fire last year for the high price of its device to treat opioid overdoses, said on Thursday it is expanding nonprescription access to the Evzio injector ...

Evzio, the first naloxone treatment specifically designed to administered to opioid overdose patients by family members or caregivers, approved in 15 weeks. FDA announced the approval of Kaléo's Evzio ...

BOSTON - The price of an injectable overdose-reversing drug designed for use by laypeople has skyrocketed, prompting outrage from first-responders, health advocates and elected officials. Kaléo, a ...

While naloxone effectively reverses the effects of an opioid overdose, medical experts said the rising price of one form of the drug may limit overall access to the life-saving medicine. Opioid ...

(Reuters) - Kaleo Inc, which came under fire last year for the high price of its device to treat opioid overdoses, on Thursday said it is expanding nonprescription access to the Evzio injector and ...

While naloxone effectively reverses the effects of an opioid overdose, medical experts said the rising price of one form of the drug may limit overall access to the life-saving medicine. Opioid ...